Staff Profile Pages

Targeting HSP90 in breast cancer: Enchant-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic breast cancer

Authors: Cameron, D.A., Hickish, T. et al.

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: 32

Issue: 15

eISSN: 1527-7755

ISSN: 0732-183X

DOI: 10.1200/jco.2014.32.15_suppl.tps665

Source: Web of Science (Lite)